Immediate Impact

1 by Nobel laureates 5 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Structural basis of NINJ1-mediated plasma membrane rupture in cell death
2023 StandoutNature
2 intermediate papers

Works of Maria Iannone being referenced

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer
2015
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
2012

Author Peers

Author Last Decade Papers Cites
Maria Iannone 260 134 134 163 25 775
Federica Crippa 215 131 86 128 27 839
Ehsan Ban 490 84 22 206 21 951
Keren Turjeman 285 406 27 305 21 976
Yanhong Wu 177 206 60 48 50 943
Jing Cheng 219 142 23 307 15 891
David Vader 503 54 30 284 17 949
Robert O. Johnson 309 160 24 78 24 945
Hongyu Jin 313 132 15 51 47 875
Biao Han 184 144 32 114 27 889
Minhee Ku 323 255 24 85 37 783

All Works

Loading papers...

Rankless by CCL
2026